SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U107. A total of 3 filers reported holding SIERRA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $72,277,000 | +71.6% | 1,314,127 | +0.0% | 23.14% | +93.7% |
Q1 2022 | $42,114,000 | +121.1% | 1,314,012 | +49.9% | 11.95% | +158.8% |
Q4 2021 | $19,050,000 | +0.1% | 876,656 | 0.0% | 4.62% | +6.9% |
Q3 2021 | $19,031,000 | +13.2% | 876,656 | +0.6% | 4.32% | -16.9% |
Q2 2021 | $16,813,000 | +14.2% | 871,125 | 0.0% | 5.20% | +2.2% |
Q1 2021 | $14,722,000 | +5.9% | 871,125 | 0.0% | 5.08% | +6.9% |
Q4 2020 | $13,903,000 | +50.9% | 871,125 | -0.6% | 4.76% | +141.4% |
Q3 2020 | $9,212,000 | -12.6% | 876,541 | 0.0% | 1.97% | -33.1% |
Q2 2020 | $10,536,000 | +22.7% | 876,541 | 0.0% | 2.95% | -48.4% |
Q1 2020 | $8,590,000 | +11508.1% | 876,541 | +304.6% | 5.70% | +15747.2% |
Q4 2019 | $74,000 | -10.8% | 216,667 | 0.0% | 0.04% | -30.8% |
Q3 2019 | $83,000 | -31.4% | 216,667 | 0.0% | 0.05% | +13.0% |
Q2 2019 | $121,000 | -94.8% | 216,667 | -84.1% | 0.05% | -97.8% |
Q1 2019 | $2,307,000 | +21.9% | 1,365,027 | -5.5% | 2.06% | +20.1% |
Q4 2018 | $1,892,000 | -23.0% | 1,444,445 | 0.0% | 1.72% | +17.7% |
Q3 2018 | $2,456,000 | -42.6% | 1,444,445 | 0.0% | 1.46% | -40.2% |
Q2 2018 | $4,276,000 | +43.7% | 1,444,445 | 0.0% | 2.44% | +32.1% |
Q1 2018 | $2,976,000 | – | 1,444,445 | – | 1.85% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 8,112,121 | $9,491,000 | 4.86% |
New Leaf Venture Partners, L.L.C. | 2,744,088 | $3,211,000 | 2.26% |
DAFNA Capital Management LLC | 265,000 | $310,000 | 0.22% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,495,734 | $4,090,000 | 0.22% |
Perceptive Advisors | 3,655,186 | $4,277,000 | 0.22% |
NEXTHERA CAPITAL LP | 400,000 | $468,000 | 0.20% |
SABBY MANAGEMENT, LLC | 1,662,487 | $1,945,000 | 0.13% |
AWM Investment Company, Inc. | 500,000 | $585,000 | 0.10% |
VHCP Management II, LLC | 130,798 | $153,000 | 0.06% |
Orbimed Advisors | 3,703,704 | $4,333,000 | 0.04% |